110 related articles for article (PubMed ID: 19832634)
1. N-trimethyl chitosan-coated multivesicular liposomes for oxymatrine oral delivery.
Cao J; Sun J; Wang X; Li X; Deng Y
Drug Dev Ind Pharm; 2009 Nov; 35(11):1339-47. PubMed ID: 19832634
[TBL] [Abstract][Full Text] [Related]
2. N-trimethyl chitosan chloride-coated liposomes for the oral delivery of curcumin.
Chen H; Wu J; Sun M; Guo C; Yu A; Cao F; Zhao L; Tan Q; Zhai G
J Liposome Res; 2012 Jun; 22(2):100-9. PubMed ID: 22007962
[TBL] [Abstract][Full Text] [Related]
3. N-trimethyl chitosan-modified liposomes as carriers for oral delivery of salmon calcitonin.
Huang A; Makhlof A; Ping Q; Tozuka Y; Takeuchi H
Drug Deliv; 2011 Nov; 18(8):562-9. PubMed ID: 21823926
[TBL] [Abstract][Full Text] [Related]
4. Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation.
Paliwal R; Paliwal SR; Agrawal GP; Vyas SP
Int J Pharm; 2012 Jan; 422(1-2):179-84. PubMed ID: 22079712
[TBL] [Abstract][Full Text] [Related]
5. Novel O-palmitoylscleroglucan-coated liposomes as drug carriers: development, characterization and interaction with leuprolide.
Carafa M; Marianecci C; Annibaldi V; Di Stefano A; Sozio P; Santucci E
Int J Pharm; 2006 Nov; 325(1-2):155-62. PubMed ID: 16884870
[TBL] [Abstract][Full Text] [Related]
6. Muco-adhesive multivesicular liposomes as an effective carrier for transmucosal insulin delivery.
Jain AK; Chalasani KB; Khar RK; Ahmed FJ; Diwan PV
J Drug Target; 2007 Jul; 15(6):417-27. PubMed ID: 17613660
[TBL] [Abstract][Full Text] [Related]
7. Liposomes coated with N-trimethyl chitosan to improve the absorption of harmine in vivo and in vitro.
Chen WL; Yuan ZQ; Liu Y; Yang SD; Zhang CG; Li JZ; Zhu WJ; Li F; Zhou XF; Lin YM; Zhang XN
Int J Nanomedicine; 2016; 11():325-36. PubMed ID: 26855571
[TBL] [Abstract][Full Text] [Related]
8. Improved oral delivery of resveratrol from N-trimethyl chitosan-g-palmitic acid surface-modified solid lipid nanoparticles.
Ramalingam P; Ko YT
Colloids Surf B Biointerfaces; 2016 Mar; 139():52-61. PubMed ID: 26700233
[TBL] [Abstract][Full Text] [Related]
9. Formulation and comparative characterization of chitosan, gelatin, and chitosan-gelatin-coated liposomes of CPT-11-HCl.
Shende P; Gaud R
Drug Dev Ind Pharm; 2009 May; 35(5):612-8. PubMed ID: 18951273
[TBL] [Abstract][Full Text] [Related]
10. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
[TBL] [Abstract][Full Text] [Related]
11. Oral absorption enhancement of salmon calcitonin by using both N-trimethyl chitosan chloride and oligoarginines-modified liposomes as the carriers.
Huang A; Su Z; Li S; Sun M; Xiao Y; Ping Q; Deng Y
Drug Deliv; 2014 Aug; 21(5):388-96. PubMed ID: 24188463
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of tramadol PEG-coated multivesicular liposomes for sustained release.
He S; Zhu J; Xie F
Pharmazie; 2010 Jul; 65(7):467-70. PubMed ID: 20662312
[TBL] [Abstract][Full Text] [Related]
13. Inducing sustained release and improving oral bioavailability of curcumin via chitosan derivatives-coated liposomes.
Tian MP; Song RX; Wang T; Sun MJ; Liu Y; Chen XG
Int J Biol Macromol; 2018 Dec; 120(Pt A):702-710. PubMed ID: 30170061
[TBL] [Abstract][Full Text] [Related]
14. Properties of liposomes coated with hydrophobically modified chitosan in oral liposomal drug delivery.
Thongborisute J; Takeuchi H; Yamamoto H; Kawashima Y
Pharmazie; 2006 Feb; 61(2):106-11. PubMed ID: 16526556
[TBL] [Abstract][Full Text] [Related]
15. Process optimization, characterization and evaluation in vivo of oxymatrine-phospholipid complex.
Yue PF; Yuan HL; Li XY; Yang M; Zhu WF
Int J Pharm; 2010 Mar; 387(1-2):139-46. PubMed ID: 20005937
[TBL] [Abstract][Full Text] [Related]
16. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
17. Effect of a controlled-release drug delivery system made of oleanolic acid formulated into multivesicular liposomes on hepatocellular carcinoma in vitro and in vivo.
Luo Y; Liu Z; Zhang X; Huang J; Yu X; Li J; Xiong D; Sun X; Zhong Z
Int J Nanomedicine; 2016; 11():3111-29. PubMed ID: 27471381
[TBL] [Abstract][Full Text] [Related]
18. Polymer-lipid hybrid nanoparticles as enhanced indomethacin delivery systems.
Dalmoro A; Bochicchio S; Nasibullin SF; Bertoncin P; Lamberti G; Barba AA; Moustafine RI
Eur J Pharm Sci; 2018 Aug; 121():16-28. PubMed ID: 29777855
[TBL] [Abstract][Full Text] [Related]
19. [Effects of the liposomes coated by chitosan and its derivatives on the gastrointestinal transit of insulin].
Wu ZH; Ping QN; Lei XM; Li JY; Cai P
Yao Xue Xue Bao; 2005 Jul; 40(7):618-22. PubMed ID: 16196267
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacokinetics and bioavailability of sustained-release tablets of matrine in dogs].
Li ZW; Li GF; Zhang JH
Zhong Yao Cai; 2010 Aug; 33(8):1293-6. PubMed ID: 21213544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
